These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1626554)

  • 1. The end-stage renal disease program: trends over the past 18 years.
    Port FK
    Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):3-7. PubMed ID: 1626554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment modality patterns and transplantation among the United States pediatric end-stage renal disease population: a longitudinal study.
    Held PJ; Turenne MN; Liska DW; Zobel DL; Webb RL; Alexander SR; Jones C
    Clin Transpl; 1991; ():71-85. PubMed ID: 1820148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
    Port FK
    Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reimbursement regulations on patient management.
    Hull AR
    Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):8-11. PubMed ID: 1626555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
    Friedlander MA; Hricik DE
    Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A report of the Malaysian dialysis registry of the National Renal Registry, Malaysia.
    Lim YN; Lim TO; Lee DG; Wong HS; Ong LM; Shaariah W; Rozina G; Morad Z
    Med J Malaysia; 2008 Sep; 63 Suppl C():5-8. PubMed ID: 19230240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Substitutes for renal function. Technical trends and logistics of treatment].
    Legrain M; Rottembourg J
    C R Seances Soc Biol Fil; 1981; 175(5):669-93. PubMed ID: 6456794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
    Hattori S; Yosioka K; Honda M; Ito H;
    Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis therapy among elderly patients; data from the Canadian Organ Replacement Register, 1981-1991.
    Fenton SS; Desmeules M; Jeffery JR; Corman JL
    Adv Perit Dial; 1993; 9():124-9. PubMed ID: 8105905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001.
    Guo H; Kalra PA; Gilbertson DT; Liu J; Chen SC; Collins AJ; Foley RN
    Circulation; 2007 Jan; 115(1):50-8. PubMed ID: 17179020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of end stage renal disease and implications for public policy.
    Rubin RJ
    Public Health Rep; 1984; 99(5):492-8. PubMed ID: 6435162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.